Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom

This is the latest version of this eprint.

Whyte, S., Cooper, K..L, Stevenson, M.D. et al. (2 more authors) (2011) Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom. HEDS Discussion Paper , 11-01.

Abstract

Metadata

Authors/Creators:
  • Whyte, S. (sophie.whyte@sheffield.ac.uk)
  • Cooper, K..L (k.l.cooper@sheffield.ac.uk)
  • Stevenson, M.D. (m.d.stevenson@sheffield.ac.uk)
  • Madan, J.
  • Akehurst, R. (r.l.akehurst@sheffield.ac.uk)
Keywords: cost-effectiveness; economic model; febrile neutropenia; granulocyte colony–stimulating factors; prophylaxis
Dates:
  • Completed: 2011
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Health Economics and Decision Science > HEDS Discussion Paper Series
Depositing User: ScHARR / HEDS (Sheffield)
Date Deposited: 11 Jul 2012 09:17
Last Modified: 05 Jun 2014 23:41
Status: Published
Series Name: HEDS Discussion Paper

Available Versions of this Item

Download

Filename: HEDS-DP-11-01.pdf

Share / Export